Cargando…
Radionuclide therapy of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a malignant tumour of the hepatocyte. It is a common malignancy worldwide and causes almost half a million deaths annually. Asia is a high risk area. Although surgery (hepatectomy or liver transplantation) is the main form of curative treatment, the majority of pati...
Autor principal: | Sundram, FX |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097631/ https://www.ncbi.nlm.nih.gov/pubmed/21614248 http://dx.doi.org/10.2349/biij.2.3.e40 |
Ejemplares similares
-
Recent Advances in Hepatocellular Carcinoma Treatment with Radionuclides
por: Liu, Ruiqi, et al.
Publicado: (2022) -
Clinical use of PET/CT in thyroid cancer diagnosis and management
por: Sundram, FX
Publicado: (2006) -
Targeted Radionuclide Therapy
por: Ersahin, Devrim, et al.
Publicado: (2011) -
Update on radionuclide therapy in oncology
por: Nitipir, Cornelia, et al.
Publicado: (2017) -
Peptide Receptor Radionuclide Therapy
por: Hofland, Johannes, et al.
Publicado: (2022)